Trial Profile
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Dec 2015.
- 17 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2013 to 1 Dec 2015.
- 24 May 2013 New trial record